Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma

Journal of Investigative Dermatology

Volumn 131, Issue 12, 2011, Pages 2467-2476

  Greenberger, Shoshana ^a,b   Yuan, Siming ^a,c   Walsh, Logan A ^a,d   Boscolo, Elisa ^a   Kang, Kyu Tae ^a   Matthews, Benjamin ^a   Mulliken, John B ^a   Bischoff, Joyce ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c JINLING HOSPITAL   (China)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; RAPAMYCIN; ROSCOVITINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CAPILLARY HEMANGIOMA; CELL ISOLATION; CELL RENEWAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG APPROVAL; DRUG MECHANISM; DRUG POTENTIATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LONGITUDINAL STUDY; LOW DRUG DOSE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION;

EID: 80855123566     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.300     Document Type: Article

References (42)

1. Amir J, Metzker A, Krikler R et al. (1986) Strawberry hemangioma in preterm infants. Pediatr Dermatol 3:331-2 (Pubitemid 17199330)
2. Bennett ML, Fleischer AB Jr, Chamlin SL et al. (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 137:1208-13 (Pubitemid 32847844)
3. Boon LM, MacDonald DM, Mulliken JB (1999) Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 104:1616-23 (Pubitemid 29510480)
4. Boscolo E, Stewart CL, Greenberger S et al. (2011) JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31:2181-92
5. Boye E, Yu Y, Paranya G et al. (2001) Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107:745-52 (Pubitemid 32225360)
6. Chen C, Liu Y, Liu R et al. (2008) TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205:2397-408
7. Darlington GJ, Ross SE, MacDougald OA (1998) The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273:30057-60 (Pubitemid 28545461)
8. De Azevedo WF, Leclerc S, Meijer L et al. (1997) Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 243:518-26 (Pubitemid 27060442)
9. Drolet BA, Esterly NB, Frieden IJ (1999) Hemangiomas in children. N Engl J Med 341:173-81 (Pubitemid 29325746)
10. Dubrovska A, Kim S, Salamone RJ et al. (2009) The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106:268-73
11. Frieden IJ, Drolet BA (2009) Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol 26:642-4
12. Geerts AM, Vanheule E, Van Vlierberghe H et al. (2008) Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice. Hepatol Res 38:1130-9
13. Greenberger S, Boscolo E, Adini I et al. (2010) Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 362:1005-13
14. Groszer M, Erickson R, Scripture-Adams DD et al. (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294:2186-9 (Pubitemid 33150679)
15. Guba M, von Breitenbuch P, Steinbauer M et al. (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128-35 (Pubitemid 34155123)
16. Haggstrom AN, Lammer EJ, Schneider RA et al. (2006) Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117:698-703 (Pubitemid 46063211)
17. Hall PA, Levison DA (1990) Review: assessment of cell proliferation in histological material. J Clin Pathol 43:184-92 (Pubitemid 20087565)
18. Hara K, Yonezawa K, Kozlowski MT et al. (1997) Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem 272:26457-63 (Pubitemid 27458864)
19. Hill R, Wu H (2009) PTEN, stem cells, and cancer stem cells. J Biol Chem 284:11755-9
20. Hirschi KK, Rohovsky SA, D'Amore PA (1998) PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805-14 (Pubitemid 28217923)
21. Ingram DA, Mead LE, Tanaka H et al. (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-60 (Pubitemid 39434958)
22. Inoue-Narita T, Hamada K, Sasaki T et al. (2008) Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis. Cancer Res 68:5760-8
23. Khan ZA, Boscolo E, Picard A et al. (2008) Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118:2592-9 (Pubitemid 351949786)
24. Khan ZA, Melero-Martin JM, Wu X et al. (2006) Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 108:915-21 (Pubitemid 44154625)
25. Kharas MG, Okabe R, Ganis JJ et al. (2010) Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 115: 1406-15
26. Leaute-Labreze C, Dumas de la Roque E, Hubiche T et al. (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358: 2649-51 (Pubitemid 351831393)
27. Li L, Miano JM, Cserjesi P et al. (1996) SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 78:188-95
28. Loveless ME, Whisenant JG, Wilson K et al. (2009) Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model. Mol Imaging 8:187-98
29. Meijer L, Borgne A, Mulner O et al. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243: 527-36 (Pubitemid 27060443)
30. Melero-Martin JM, De Obaldia ME, Kang SY et al. (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103:194-202
31. Melero-Martin JM, Khan ZA, Picard A et al. (2007) In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109:4761-8 (Pubitemid 46827769)
32. Mulliken JB (1988) Diagnosis and natural history of hemangiomas. In: Vascular Birthmarks: Hemangiomas And Malformations (Mulliken JB, ed), WB Saunders: Philadelphia
33. Olive KP, Jacobetz MA, Davidson CJ et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324:1457-61
34. Phung TL, Eyiah-Mensah G, O'Donnell RK et al. (2007) Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression. Cancer Res 67:5070-5 (Pubitemid 46997240)
35. Prelich G, Tan CK, Kostura M et al. (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517-20 (Pubitemid 17055499)
36. Siegfried EC, Keenan WJ, Al-Jureidini S (2008) More on propranolol for hemangiomas of infancy. N Engl J Med 359:2846
37. Sindhi R, Seward J, Mazariegos G et al. (2005) Replacing calcine-urin inhibitors with mTOR inhibitors in children. Pediatr Transplant 9:391-7 (Pubitemid 40780373)
38. Wu PA, Mancini AJ, Marghoob AA et al. (2008) Simultaneous occurrence of infantile hemangioma and congenital melanocytic nevus: Coincidence or real association? J Am Acad Dermatol 58:S16-22
39. Yilmaz OH, Valdez R, Theisen BK et al. (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475-82 (Pubitemid 44050144)
40. Zhang HH, Huang J, Duvel K et al. (2009) Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE 4:e6189
41. Zhang J, Grindley JC, Yin T et al. (2006) PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441:518-22 (Pubitemid 44050154)
42. Zhou J, Su P, Wang L et al. (2009) mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc Natl Acad Sci USA 106:7840-5